Premium
Surgery of iris melanoma
Author(s) -
Mouriaux F.
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2017.02345
Subject(s) - medicine , iris (biosensor) , surgery , radiation therapy , resection , melanoma , surgical resection , computer security , cancer research , computer science , biometrics
Summary The most effective treatment for iris nevus and melanoma remains debatable. Typically, a melanocytic iris nevus is monitored until growth is identified. With documented growth, radiotherapy or surgical resection is usually performed. Surgical resection consists of iridectomy, which is characterized by removal of part of the iris with the tumor. Rates of cataract and glaucoma development after treatment are generally higher following proton beam and plaque radiotherapy relative to surgical resection. Moreover, radiotherapy carries the risk of limbal stem cell deficiency. Finally, surgical resection does carry the rapidity of tumor removal. Thus, localized, circumscribed, or discrete lesions that demonstrate growth are excellent candidates for conservative surgical resection.